Der Klinikarzt 2014; 43(2): 94-99
DOI: 10.1055/s-0034-1371968
Schwerpunkt
© Georg Thieme Verlag Stuttgart · New York

Ventrikuläre Tachykardien – Behandlung in einer „VT-Unit“

Ventricular tachycardia – Treatment in a „VT-Unit“
Christian Meyer
1   Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf
,
Bita Gholamalizadeh
1   Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf
› Author Affiliations
Further Information

Publication History

Publication Date:
28 February 2014 (online)

Ventrikuläre Tachykardien (VT) sind eine der häufigsten Todesursachen von Patienten mit struktureller Herzerkrankung. Betroffene Patienten weisen häufig vielschichtige Komorbiditäten und eine erhöhte Mortalität auf. Die vielseitigen Ursachen sowie die zunehmenden Behandlungsmöglichkeiten erfordern insbesondere bei wiederholten oder nicht beherrschbaren VT eine umgehende und strukturierte Betreuung betroffener Patienten in einem speziell ausgebildeten Team aus Ärzten verschiedener Sub-Disziplinen, sowie Pflege- und technischem Personal. Vor diesem Hintergrund wurden an einigen Schwerpunktzentren in der jüngeren Vergangenheit gezielte Versorgungsstrukturen geschaffen, durch welche eine rasche und effiziente Behandlung von VT erreicht werden kann. Ziel der vorliegenden Arbeit ist es, mögliche Versorgungswege darzustellen. Aufgrund der zunehmenden Bedeutung der Katheterablation zur Modifizierung des zugrunde liegenden arrhythmogenen Substrats und neuer neuromodulatorischer Interventionen wird insbesondere auch auf periprozedurale Aspekte eingegangen, die in der Indikationsstellung sowie der Nachbetreuung der Patienten von besonderer Bedeutung sind.

Ventricular tachycardia (VT) are one of the most common causes of death in patients with structural heart disease. The increasing understanding of different etiologies and the rising number of therapeutical interventions of recurrent VT warrant an immedeate and structurized treatment in an interdisciplinary team of different health care professionals. Grounded in this knowledge dedicated VT units have been established in some centers. The aim of the present brief review is to discuss possible options which might increase health management in a relevant number of patients with VT who are at risk of sudden cardiac death. In the light of recent developments, we will address periprocedural aspects which are important for patients undergoing radiofrequency cather ablation for myocardial substrate modification and/or newer neuromodulating approaches.

 
  • Literatur

  • 1 Carbucicchio C, Santamaria M, Trevisi N et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 2008; 117: 462-469
  • 2 Meyer C, Martinek M, Winter S et al. Arrhythmias in patients with surgically corrected tetralogy of Fallot. Herzschrittmacherther Elektrophysiol 2010; 21: 189-195
  • 3 Della BP, Baratto F, Tsiachris D et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation. Circulation 2013; 127: 1359-1368
  • 4 Aliot EM, Stevenson WG, Mendral-Garrote JM et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm 2009; 6: 886-933
  • 5 Meyer C, Martinek M, Aichinger J et al. Catheter ablation of premature ventricular complexes in a patient with progressive heart failure. Herzschrittmacherther Elektrophysiol 2011; 22: 49-52
  • 6 Blomstrom LC, Auricchio A, Brugada J et al. The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology. Europace 2013; 15: 927-936
  • 7 Meyer C, Martinek M, Hassanein S et al. Endo- and epicardial catheter ablation preventing ventricular tachycardia: impact of substrate modification. Wien Med Wochenschr 2010; 160: 517-525
  • 8 Jais P, Maury P, Khairy P et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation 2012; 125: 2184-2196
  • 9 Vergara P, Trevisi N, Ricco A et al. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol 2012; 23: 621-627
  • 10 Berruezo A, Fernandez-Armenta J, Mont L et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol 2012; 5: 111-121
  • 11 Eickholt C, Mischke K, Schimpf T et al. Functional and topographic concordance of right atrial neural structures inducing sinus tachycardia. Adv Exp Med Biol 2013; 788: 273-282
  • 12 Meyer C, Rana OR, Saygili E et al. Augmentation of left ventricular contractility by cardiac sympathetic neural stimulation. Circulation 2010; 121: 1286-1294
  • 13 Odero A, Bozzani A, De Ferrari GM, Schwartz PJ. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. Heart Rhythm 2010; 7: 1161-1165
  • 14 Bourke T, Vaseghi M, Michowitz Y et al. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 2010; 121: 2255-2262
  • 15 Hoffmann BA, Steven D, Willems S, Sydow K. Renal Sympathetic Denervation as an Adjunct to Catheter Ablation for the Treatment of Ventricular Electrical Storm in the Setting of Acute Myocardial Infarction. J Cardiovasc Electrophysiol 2013; 24
  • 16 Ukena C, Bauer A, Mahfoud F et al. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 2012; 101: 63-67
  • 17 Ajijola OA, Lellouche N, Bourke T et al. Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol 2012; 59: 91-92
  • 18 Vaseghi M, Gima J, Kanaan C et al. Cardiac Sympathetic Denervation In Patients With Refractory Ventricular Arrhythmias Or Electrical Storm: Intermediate And Long Term Follow Up. Heart Rhythm 2013; 28: 1547-5271